The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
There is a growing body of evidence indicating a close association between inflammatory
bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive …
bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive …
Organoruthenium-bipyridyl complexes–A platform for diverse chemistry and applications
C Pandya, A Sivaramakrishna - Coordination Chemistry Reviews, 2024 - Elsevier
The increasing impact of organometallic complexes of group 8–10 metals academically and
industrially over the years demonstrates remarkable progress in harvesting useful reagents …
industrially over the years demonstrates remarkable progress in harvesting useful reagents …
Ruthenium-based metal-organic framework with reactive oxygen and nitrogen species scavenging activities for alleviating inflammation diseases
J Liu, L Shi, Y Wang, M Li, C Zhou, L Zhang, C Yao… - Nano Today, 2022 - Elsevier
The overproduction of reactive oxygen and nitrogen species (RONS) is highly associated
with a variety of inflammatory diseases. Nevertheless, few treatments are clinically available …
with a variety of inflammatory diseases. Nevertheless, few treatments are clinically available …
Increasing anticancer activity with phosphine ligation in zwitterionic half-sandwich iridium (III), rhodium (III), and ruthenium (II) complexes
X Hu, L Guo, M Liu, Q Zhang, Y Gong, M Sun… - Inorganic …, 2022 - ACS Publications
The synthesis and biological assessment of neutral or cationic platinum group metal-based
anticancer complexes have been extremely studied, whereas there are few reports on the …
anticancer complexes have been extremely studied, whereas there are few reports on the …
Inhibition of amyloid β1–42 peptide aggregation by newly designed cyclometallated palladium complexes
Uncontrolled amyloid aggregation is a frequent cause of neurodegenerative disorders such
as prions and Alzheimer's disease (AD). As a result, many drug development approaches …
as prions and Alzheimer's disease (AD). As a result, many drug development approaches …
Design and synthesis of piano-stool ruthenium (II) complexes and their studies on the inhibition of amyloid β (1–42) peptide aggregation
Misfolding and protein aggregation have been linked to numerous human
neurodegenerative disorders such as Alzheimer's, prion, and Parkinson's diseases …
neurodegenerative disorders such as Alzheimer's, prion, and Parkinson's diseases …
DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium (II) complexes
The chemotherapeutic potential of ruthenium (II) complexes has recently attracted
researchers' interest as antibacterial and anticancer agents. In this study, two novel half …
researchers' interest as antibacterial and anticancer agents. In this study, two novel half …
Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation
Neurodegenerative disorders (NDDs) are a class of debilitating diseases that progressively
impair the protein structure and result in neurological dysfunction in the nervous system …
impair the protein structure and result in neurological dysfunction in the nervous system …
Metal complexes as promising matrix metalloproteinases regulators
Nowadays, cancers and dementia, such as Alzheimer's disease, are the most fatal causes of
death. Many studies tried to understand the pathogenesis of those diseases clearly and …
death. Many studies tried to understand the pathogenesis of those diseases clearly and …
An overview of the potential medicinal and pharmaceutical properties of Ru (II)/(III) complexes
A Skoczynska, A Lewinski, M Pokora, P Paneth… - International Journal of …, 2023 - mdpi.com
This review examines the existing knowledge about Ru (II)/(III) ion complexes with a
potential application in medicine or pharmacy, which may offer greater potential in cancer …
potential application in medicine or pharmacy, which may offer greater potential in cancer …